BEST1 and autosomal recessive bestrophinopathy: In this study, we sought to find more potent drugs for treatment of the bestrophinopathies by virtually screening a library of FDA compounds into a model of the COPII Sec 24a binding site, where 4PBA, a rescuer of mutant Best1 function, has been shown to bind [9,19].